Barinthus Biotherapeutics
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc.
Company type | Public |
---|---|
Nasdaq: BRNS | |
Industry | |
Founded | 2016 |
Founder | |
Headquarters | , United Kingdom |
Website | barinthusbio |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.